Liver damage profile in COVID-19 pregnant patients

被引:2
|
作者
Januszewski, Marcin [1 ]
Ziuzia-Januszewska, Laura [2 ]
Kudan, Michal [1 ]
Pluta, Kamil [1 ]
Klapaczynski, Jakub [3 ]
Wierzba, Waldemar [1 ]
Maciejewski, Tomasz [4 ]
Jakimiuk, Alicja A. [5 ]
Jakimiuk, Artur J. [1 ,6 ]
机构
[1] Minist Interior & Adm, Natl Med Inst, Dept Obstet & Gynecol, Woloska 137, PL-02507 Warsaw, Poland
[2] Minist Interior & Adm, Natl Med Inst, Dept Otolaryngol, Woloska 137, PL-02507 Warsaw, Poland
[3] Minist Interior & Adm, Natl Med Inst, Dept Hepatol, Woloska 137, PL-02507 Warsaw, Poland
[4] Inst Mother & Child Hlth, Dept Obstet & Gynecol, Kasprzaka 17a, PL-01211 Warsaw, Poland
[5] Minist Interior & Adm, Natl Med Inst, Dept Plast Surg, Woloska 137, PL-02507 Warsaw, Poland
[6] Inst Mother & Child Hlth, Ctr Reprod Hlth, Kasprzaka 17a, PL-01211 Warsaw, Poland
关键词
COVID-19; Liver damage; Pregnancy; Bile acids; SARS-CoV-2; SARS-COV-2; INFECTION; CHOLESTASIS;
D O I
10.1186/s12964-023-01285-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IntroductionSARS-CoV-2 unsparingly impacts all areas of medicine. Pregnant women are particularly affected by the pandemic and COVID-19 related liver damage seems to be another threat to maternal and fetal health. The aim of this study is to define liver damage profile including bile acids serum levels in COVID-19 pregnant patients and to determine predictors of disease aggravation and poor obstetrics outcomes.MethodsThis study has been carried out in the Obstetrics and Gynecology Department, at the National Medical Institute in Warsaw, Poland between 01.02.2021 and 01.11.2022 The study cohort comprises 148 pregnant patients with COVID-19 and 102 pregnant controls who has been tested negative for SARS-CoV-2.ResultsCOVID-19 pregnant patients presented liver involvement at admission in 41,9%. Hepatotoxic damage accounted for 27 (19.85%), cholestatic type was diagnosed in 11 (8.09%) and mixed type of liver injury was presented in 19 (13.97%) of patients. Higher serum levels of AST, ALT, GGT, total bilirubin and bile acids as well as mixed type of liver injury at admission were correlated with severe form of an illness. AST and ALT above upper reference limit as well as hepatotoxic type of liver damage predisposed pregnant patients with COVID-19 to poor obstetrics outcomes.ConclusionHepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes.DaRpyovs-oA9XgYzu_a_v9Video AbstractConclusionHepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes.DaRpyovs-oA9XgYzu_a_v9Video Abstract
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Pregnant Patients with COVID-19 Admitted to an ICU: A Comparison with a Historical Cohort of Critical Pregnant Patients without COVID-19
    Iacovazzo, Carmine
    Capasso, Letizia
    Visani, Carola
    Salome, Serena
    Vargas, Maria
    LIFE-BASEL, 2024, 14 (02):
  • [22] Liver and COVID-19: possible mechanisms of damage
    Mnatsakanyan, Marina G.
    Pogromov, Aleksandr P.
    Lishuta, Aleksei S.
    Fomin, Victor V.
    Volkova, Olga S.
    Tashchyan, Olga, V
    Kuprina, Irina, V
    Shumskaya, Yuliia F.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (04) : 427 - 430
  • [23] T helper profile in pregnant women recovered from COVID-19 br
    Tartaglia, Eleonora
    Bordoni, Veronica
    Oliva, Alessandra
    Vergori, Alessandra
    Girardi, Enrico
    Antinori, Andrea
    Agrati, Chiara
    Liuzzi, Giuseppina
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 153
  • [24] Dexamethasone and Remdesivir for the Mitigation of COVID-19 Symptoms in Pregnant Patients
    Rivera-Alsina, Manuel E.
    Antony, Suresh J.
    Vega, Oscar
    Garcia, Jacob
    Mendez, Melissa
    JOURNAL OF REPRODUCTIVE MEDICINE, 2021, 66 (11-12) : 321 - 326
  • [25] Coagulation Profile of COVID-19 Patients
    Kaiafa, Georgia
    Savopoulos, Christos
    Karlafti, Eleni
    Pantazi, Konstantina
    Paramythiotis, Daniel
    Thomaidou, Evanthia
    Daios, Stylianos
    Ztriva, Eleftheria
    Gionis, Michalis
    Fyntanidou, Varvara
    Argiriadou, Helena
    Didangelos, Triantafyllos
    LIFE-BASEL, 2022, 12 (10):
  • [26] A Review of Cardiovascular Complications among Pregnant Patients with COVID-19
    Pruzansky, Alix J.
    Slade, Justin J.
    Stephenson, Megan
    Pursnani, Seema
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (11)
  • [27] COVID-19 disease and vaccination in pregnant and lactating women
    Safadi, Marco A. P.
    Spinardi, Julia
    Swerdlow, David
    Srivastava, Amit
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 88 (01)
  • [28] Is the Immunization of Pregnant Women against COVID-19 Justified?
    Principi, Nicola
    Esposito, Susanna
    VACCINES, 2021, 9 (09)
  • [29] The clinical characteristics and underlying causes of liver damage in patients with COVID-19 infection: Retrospective analysis
    Zuo, Guojin
    Liu, Weirong
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (05) : 1282 - 1287
  • [30] Treatment With Remdesivir in Two Pregnant Patients With COVID-19 Pneumonia
    Singh, Vinita
    Choudhary, Anisha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)